NEXTURN&ROLLKOREA Co., Ltd
Financials
Valuation Metrics
NEXTURN&ROLLKOREA Co., Ltd's Market Cap is ₩304B. At end of 2025 it was ₩333B. Ranked #2028 of 2,405 in KR market (top 84%), #1286 of 1,627 on KOSDAQ (top 79%), #320 of 361 in Capital Goods (top 89%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 30.39B KRW | KR#2,028/2,405 Sec#320/361 |
| Revenue | 112.61B KRW | KR#1,349/2,405 Sec#222/361 |
| Net Income | 1.61B KRW | KR#1,439/2,405 Sec#224/361 |
| Total Assets | 313.67B KRW | KR#1,009/2,405 Sec#174/361 |
| Net Assets | 238.49B KRW | KR#850/2,405 Sec#150/361 |
| Employees | 57 | KR#1,979/2,405 Sec#298/361 |
| Value | ||
| P/E | 18.89x | KR#1,185/2,405 Sec#180/361 |
| P/B | 0.13x | KR#40/2,405 Sec#8/361 |
| PEG | 0.21x | KR#588/2,405 Sec#91/361 |
| P/S | 0.27x | KR#569/2,405 Sec#90/361 |
| EV/EBITDA | 3.31x | KR#132/2,405 Sec#15/361 |
| FCF Yield | -19.76% | KR—/2,405 Sec—/361 |
| Profitability | ||
| ROE | 0.67% | KR#1,503/2,405 Sec#232/361 |
| ROA | 0.51% | KR#1,476/2,405 Sec#229/361 |
| Op. Margin | 12.06% | KR#417/2,405 Sec#60/361 |
| Revenue Growth | 197.35% | KR#39/2,405 Sec#4/361 |
| Earnings Growth | 88.72% | KR#421/2,405 Sec#60/361 |
| Financial Health | ||
| Debt Ratio | 31.52% | KR#611/2,405 Sec#70/361 |
| Total Debt | 48.18B KRW | KR#1,018/2,405 Sec#178/361 |
| FCF | -6.01B KRW | KR#1,536/2,405 Sec#230/361 |
| Cash | 33.61B KRW | KR#940/2,405 Sec#163/361 |
| Current Ratio | 2.49x | KR#689/2,405 Sec#78/361 |
| Net Debt/EBITDA | 1.07x | KR#742/2,405 Sec#93/361 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,405 Sec—/361 |
| Performance | ||
| 1Y Return | -12.21% | KR#792/2,405 Sec#117/361 |
| 1M Return | -8.15% | KR#999/2,405 Sec#107/361 |
| From 52W High | -38.95% | KR#715/2,405 Sec#74/361 |
| 1Y MDD | -38.13% | KR#497/2,405 Sec#56/361 |
| Trading | ||
| Volume | 16,612 shares | KR#1,604/2,405 Sec#274/361 |
| Trading Value | 33.0M KRW | KR#1,923/2,405 Sec#314/361 |
| Foreign Own. | 1.38% | KR#1,863/2,405 Sec#287/361 |
| Per Share | ||
| EPS | 105 KRW | KR#1,415/2,405 Sec#225/361 |
| BPS | 15,571 KRW | KR#678/2,405 Sec#117/361 |
Company Info
Established in 2000 for manufacturing and selling CNC automatic lathes, the company changed its name to Nexturn Bioscience in 2021 and was listed on KOSDAQ in 2006. It supplies CNC automatic lathes to diverse industries including automotive, communication equipment, medical parts, and electronic home appliances, and also operates businesses in heavy equipment components and semiconductor equipment. Through in-house technology development, it expanded market share with unmanned automation processing equipment. The company is pursuing entry into the new medical device business after successfully completing a national project to develop a cardiovascular interventional procedure assistance robot. Nexturn & Rol Korea was established in 2000 and is headquartered in Yongin-si, Gyeonggi-do.